Autonomous beating rate adaptation in human stem cell-derived cardiomyocytes

Nature Communications

Volumn 7, Issue , 2016, Pages

  Eng, George ^a,b   Lee, Benjamin W ^a,b   Protas, Lev ^c   Gagliardi, Mark ^d   Brown, Kristy ^e   Kass, Robert S ^c   Keller, Gordon ^d   Robinson, Richard B ^c   Vunjak Novakovic, Gordana ^a,c  

^a Department of Earth and Environmental Sciences   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

^c NONE   (United States)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAP JUNCTION PROTEIN; POTASSIUM CHANNEL HERG; KCNH2 PROTEIN, HUMAN;

CARDIOVASCULAR DISEASE; CELLS AND CELL COMPONENTS; ELECTROCHEMICAL METHOD; GENE EXPRESSION; MATURATION; MEDICINE;

ADAPTATION; ARTICLE; CELL CULTURE; CELL MATURATION; ELECTROSTIMULATION; HEART AUTOMATICITY; HEART BEAT; HEART MUSCLE CELL; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; STEM CELL; CARDIAC MUSCLE CELL; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; METABOLISM; PHYSIOLOGY; PLURIPOTENT STEM CELL; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

CELL DIFFERENTIATION; CONNEXINS; ELECTRIC STIMULATION; ERG1 POTASSIUM CHANNEL; ETHER-A-GO-GO POTASSIUM CHANNELS; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS;

EID: 84955589449     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10312     Document Type: Article

References (68)

1. Mathers, C. D. & Loncar, D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 3, e442 (2006).
2. van Berlo, J. H. & Molkentin, J. D. An emerging consensus on cardiac regeneration. Nat. Med. 20, 1386-1393 (2014).
3. Kehat, I. et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 108, 407-414 (2001).
4. Zhang, J. et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 104, e30-e41 (2009).
5. Laflamme, M. A. & Murry, C. E. Heart regeneration. Nature 473, 326-335 (2011).
6. Shiba, Y. et al. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 489, 322-325 (2012).
7. Kehat, I. et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat. Biotechnol. 22, 1282-1289 (2004).
8. Chong, J. J. et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 510, 273-277 (2014).
9. Ye, L. et al. Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell 15, 750-761 (2014).
10. Chen, H. S., Kim, C. & Mercola, M. Electrophysiological challenges of cell-based myocardial repair. Circulation 120, 2496-2508 (2009).
11. Liao, S. Y. et al. Proarrhythmic risk of embryonic stem cell-derived cardiomyocyte transplantation in infarcted myocardium. Heart Rhythm 7, 1852-1859 (2010).
12. Mandel, Y. et al. Human embryonic and induced pluripotent stem cell-derived cardiomyocytes exhibit beat rate variability and power-law behavior. Circulation 125, 883-893 (2012).
13. Roell, W. et al. Engraftment of connexin 43-expressing cells prevents postinfarct arrhythmia. Nature 450, 819-824 (2007).
14. Gepstein, L. et al. In vivo assessment of the electrophysiological integration and arrhythmogenic risk of myocardial cell transplantation strategies. Stem Cells 28, 2151-2161 (2010).
15. Satin, J. et al. Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes. J. Physiol. 559, 479-496 (2004).
16. Olson, E. N. & Srivastava, D. Molecular pathways controlling heart development. Science 272, 671-676 (1996).
17. Hirota, A., Kamino, K., Komuro, H., Sakai, T. & Yada, T. Early events in development of electrical activity and contraction in embryonic rat heart assessed by optical recording. J. Physiol. 369, 209-227 (1985).
18. Vunjak Novakovic, G., Eschenhagen, T. & Mummery, C. Myocardial tissue engineering: in vitro models. Cold Spring Harb. Perspect. Med. 4, a014076 (2014).
19. Vunjak-Novakovic, G. & Scadden, D. T. Biomimetic platforms for human stem cell research. Cell Stem Cell 8, 252-261 (2011).
20. Radisic, M. et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc. Natl Acad. Sci. USA 101, 18129-18134 (2004).
21. Serena, E. et al. Electrical stimulation of human embryonic stem cells: cardiac differentiation and the generation of reactive oxygen species. Exp. Cell Res. 315, 3611-3619 (2009).
22. Nunes, S. S. et al. Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat. Methods 10, 781-787 (2013).
23. Tandon, N. et al. Electrical stimulation systems for cardiac tissue engineering. Nat. Protoc. 4, 155-173 (2009).
24. Sathaye, A., Bursac, N., Sheehy, S. & Tung, L. Electrical pacing counteracts intrinsic shortening of action potential duration of neonatal rat ventricular cells in culture. J. Mol. Cell. Cardiol. 41, 633-641 (2006).
25. Lieu, D. K. et al. Mechanism-based facilitated maturation of human pluripotent stem cell-derived cardiomyocytes. Cir. 6, 191-201 (2013).
26. Yang, L. et al. Human cardiovascular progenitor cells develop from a KDR embryonic-stem-cell-derived population. Nature 453, 524-528 (2008).
27. Kattman, S. J. et al. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 8, 228-240 (2011).
28. Doss, M. X. et al. Maximum diastolic potential of human induced pluripotent stem cell-derived cardiomyocytes depends critically on I(Kr). PLoS ONE 7, e40288 (2012).
29. Yanagi, K. et al. Hyperpolarization-activated cyclic nucleotide-gated channels and T-type calcium channels confer automaticity of embryonic stem cell-derived cardiomyocytes. Stem Cells 25, 2712-2719 (2007).
30. Rosen, M. R., Robinson, R. B., Brink, P. R. & Cohen, I. S. The road to biological pacing. Nat. Rev. Cardiol. 8, 656-666 (2011).
31. Zhao, X. et al. In vitro characterization of HCN channel kinetics and frequency dependence in myocytes predicts biological pacemaker functionality. J. Physiol. 587, 1513-1525 (2009).
32. Kreuzberg, M. M., Willecke, K. & Bukauskas, F. F. Connexin-mediated cardiac impulse propagation: connexin 30. 2 slows atrioventricular conduction in mouse heart. Trends Cardiovasc. Med. 16, 266-272 (2006).
33. King, J. H., Huang, C. L. & Fraser, J. A. Determinants of myocardial conduction velocity: implications for arrhythmogenesis. Front. Physiol. 4, 154 (2013).
34. Gourdie, R. G., Mima, T., Thompson, R. P. & Mikawa, T. Terminal diversification of the myocyte lineage generates Purkinje fibers of the cardiac conduction system. Development 121, 1423-1431 (1995).
35. Kojima, K., Kaneko, T. & Yasuda, K. Role of the community effect of cardiomyocyte in the entrainment and reestablishment of stable beating rhythms. Biochem. Biophys. Res. Commun. 351, 209-215 (2006).
36. Sepulveda, M., Gonano, L. A., Back, T. G., Chen, S. R. & Vila Petroff, M. Role of CaMKII and ROS in rapid pacing-induced apoptosis. J. Mol. Cell. Cardiol. 63, 135-145 (2013).
37. Kuramochi, Y., Guo, X., Sawyer, D. B. & Lim, C. C. Rapid electrical stimulation induces early activation of kinase signal transduction pathways and apoptosis in adult rat ventricular myocytes. Exp. Physiol. 91, 773-780 (2006).
38. Schild, L. et al. Rapid pacing of embryoid bodies impairs mitochondrial ATP synthesis by a calcium-dependent mechanism-a model of in vitro differentiated cardiomyocytes to study molecular effects of tachycardia. Biochim. Biophys. Acta. 1762, 608-615 (2006).
39. Kim, J. J. et al. Mechanism of automaticity in cardiomyocytes derived from human induced pluripotent stem cells. J. Mol. Cell. Cardiol. 81, 81-93 (2015).
40. Wang, G. et al. Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nat. Med. 20, 616-623 (2014).
41. Hansen, A. et al. Development of a drug screening platform based on engineered heart tissue. Circ. Res. 107, 35-44 (2010).
42. Shen, D., Cheng, K. & Marban, E. Dose-dependent functional benefit of human cardiosphere transplantation in mice with acute myocardial infarction. J. Cell. Mol. Med. 16, 2112-2116 (2012).
43. Godier-Furnemont, A. F. et al. Physiologic force-frequency response in engineered heart muscle by electromechanical stimulation. Biomaterials 60, 82-91 (2015).
44. Doppler, S. A., Deutsch, M. A., Lange, R. & Krane, M. Cardiac regeneration: current therapies-future concepts. J. Thorac. Dis. 5, 683-697 (2013).
45. Caspi, O. et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J. Am. Coll. Cardiol. 50, 1884-1893 (2007).
46. Nelson, T. J. et al. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120, 408-416 (2009).
47. Juhas, M., Engelmayr, Jr G. C., Fontanella, A. N., Palmer, G. M. & Bursac, N. Biomimetic engineered muscle with capacity for vascular integration and functional maturation in vivo. Proc. Natl Acad. Sci. USA 111, 5508-5513 (2014).
48. Vandenberg, J. I. et al. hERG K() channels: structure, function, and clinical significance. Physiol. Rev. 92, 1393-1478 (2012).
49. Sale, H. et al. Physiological properties of hERG 1a/1b heteromeric currents and a hERG 1b-specific mutation associated with Long-QT syndrome. Circ. Res. 103, e81-e95 (2008).
50. Jones, D. K. et al. hERG 1b is critical for human cardiac repolarization. Proc. Natl Acad. Sci. USA 111, 18073-18077 (2014).
51. Bristow, M. R. et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N. Engl. J. Med. 350, 2140-2150 (2004).
52. Yu, C. M. et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 112, 1580-1586 (2005).
53. Aiba, T. et al. Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy. Circulation 119, 1220-1230 (2009).
54. Delorme, B. et al. Developmental regulation of connexin 40 gene expression in mouse heart correlates with the differentiation of the conduction system. Dev. Dyn. 204, 358-371 (1995).
55. Maass, K. et al. Isolation and Characterization of ESC-Derived Cardiac Purkinje Cells. Stem Cells 33, 1102-1112 (2014).
56. Dangman, K. H. et al. Electrophysiologic characteristics of human ventricular and Purkinje fibers. Circulation 65, 362-368 (1982).
57. Lee, F. Y. et al. Electromechanical properties of Purkinje fiber strands isolated from human ventricular endocardium. J. Heart Lung Transplant 23, 737-744 (2004).
58. Kehat, I., Gepstein, A., Spira, A., Itskovitz-Eldor, J. & Gepstein, L. High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: a novel in vitro model for the study of conduction. Circ. Res. 91, 659-661 (2002).
59. Thompson, S. A. et al. Engraftment of human embryonic stem cell derived cardiomyocytes improves conduction in an arrhythmogenic in vitro model. J. Mol. Cell. Cardiol. 53, 15-23 (2012).
60. Kloss, D. et al. Microcavity array (MCA)-based biosensor chip for functional drug screening of 3D tissue models. Biosens. Bioelectron. 23, 1473-1480 (2008).
61. Musick, K., Khatami, D. & Wheeler, B. C. Three-dimensional micro-electrode array for recording dissociated neuronal cultures. Lab. Chip. 9, 2036-2042 (2009).
62. Mehta, R. H. et al. Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. JAMA 301, 1779-1789 (2009).
63. Kamgoue, A., Ohayon, J., Usson, Y., Riou, L. & Tracqui, P. Quantification of cardiomyocyte contraction based on image correlation analysis. Cytometry A 75, 298-308 (2009).
64. Sun, R., Bouchard, M. B. & Hillman, E. M. SPLASSH: open source software for camera-based high-speed, multispectral in-vivo optical image acquisition. Biomed. Opt. Express 1, 385-397 (2010).
65. Reich, M. et al. GenePattern 2. 0. Nat. Genet. 38, 500-501 (2006).
66. Stovicek, P. et al. QT dispersion in 120 electrocardiographic leads in patients with structural heart disease. Pacing Clin. Electrophysiol. 25, 20-31 (2002).
67. Shlyonsky, V., Goolaerts, A., Mies, F. & Naeije, R. Electrophysiological characterization of rat type II pneumocytes in situ. Am. J. Respir. Cell Mol. Biol. 39, 36-44 (2008).
68. Ghiaroni, V., Fieni, F., Pietra, P. & Bigiani, A. Electrophysiological heterogeneity in a functional subset of mouse taste cells during postnatal development. Chem. Senses 28, 827-833 (2003).